View Older Stories View More Recent Stories
-
Verastem (VSTM) Sell-Off 'Ignores Main Value Driver', Roth Capital Says
-
Roth Capital Remains Bullish on SolarCity (SCTY) Following Investor Meetings
-
SolarCity (SCTY) Remains 'Top Pick' at Roth Following Investor Meetings
-
MoSys to Participate at the ROTH Capital Datacenter Technology Corporate Access Day on September 9
-
Roth Capital Sees Opportunity of Year-End Approval for Sarepta's (SRPT) Eteplirsen; PT Lifted to $50
-
Roth Capital Highlights Biotech Picks 'for the Turn' and Over the Long Haul (PTN) (LGND) (TGTX) (CLDX)
-
ROTH Capital Partners to Host DataCenter Technology Corporate Access Day in San Francisco, Calif. on September 9, 2015
-
Roth Capital Starts Quantum Corp. (QTM) at Buy
-
Streetinsider.com's Hot Lunchtime Reads 8/24: (AAPL) (LGND) (MON) (FCAU)
-
Roth Capital Affirms Ligand Pharma (LGND) at 'Buy' Following Expanded Promacta Indication
-
Roth Capital Positive on Peregrine Pharma (PPHM) Amid New Immunotherapy Collaboration (AZN)
-
Roth Capital Cuts Price Target on Synergy Resources (SYRG) to Reflect New Oil Price Forecast.
-
Notable Analyst Rating Changes 8/21: (SYMC) (CMPR) (CSIQ) Upgraded; (CPA) (LUX) (SSI) Downgraded
-
Roth Capital Positive on BioBlast Pharma (ORPN) Following Q2 Report; H215 Should be Busy with Phase 3 Initiations
-
Roth Capital Starts Hanwha Q CELLS (HQCL) at Buy
-
GigOptix (GIG) Prices 9.22M Common Stock Offering at $1.70/Share
-
GigOptix, Inc. Announces Pricing of Public Offering of Common Stock to Support Enhanced Strategic Growth Through Acquisitions
-
GigOptix (GIG) Announces Common Stock Offering
-
GigOptix, Inc. Announces Proposed Public Offering of Common Stock to Support Enhanced Strategic Growth Through Acquisitions
-
Roth Capital Affirms BioLineRx (BLRX) at 'Buy' Following Q2 Results; BL-8040 Continues to be Main Driver
-
Roth Remains Positive on VBL Therapeutics (VBLT) as VB-111 Phase 3 in rGBM Commences
-
Palatin (PTN) 'Sitting Pretty' After Valeant/Sprout Deal - Roth Capital
-
Palatin's (PTN) BMT Thesis Improves with Recent Sprout Pharma News - Roth Capital (VRX)
-
xG Technology, Inc. Announces Closing of Public Offering
-
Flibanserin Approval Seen as Positive Read-Thru for Sarepta Therapeutics (SRPT), Others - Roth Capital
-
Roth Capital Raises Price target on Energy Focus (EFOI) to $23 Following Recent Volatility
-
Roth Lifts PT on Energy Focus (EFOI) to $23; No Longer Overlooked in Broader Lighting Segment
-
Roth Capital Cuts Price Target on Energy Fuels (UUUU) Following 2Q15 Results
-
Telesta Therapeutics Closes US$28.6 Million Private Placement
-
Palatin Technologies' (PTN) BMT Has Advantages Over Flibanserin, Says Roth
-
Roth Capital Trims PT on Trina Solar (TSL) to $15; China Market Weakness Offsetting Module Strength
-
Roth Capital Trims PT on Canadian Solar (CSIQ) Following Q2 Results, Outlook; Notes Yieldco Remains 'on Track'
-
Roth Capital Affirms Omeros (OMER) at 'Buy' Following Quantified OMS721 Data; Longer-Term Needed for Soliris Comparison
-
Roth Capital Cuts Price Target on Marathon Patent Group (MARA) Following 2Q EPS Miss
-
Roth Capital Reiterates Buy on Quicklogic Corp (QUIK) Seeing Design Wins on Wearables
-
Revel Systems, POS Industry Leader, Extends its Series C to $110 Million to Expand its Industry Leadership
-
Roth Capital Remains Cautiously Optimistic on Spectrum Pharma (SPPI) Following Apaziquone Phase 3 SPA Agreement
-
GPM Reminds Investors of the Upcoming Deadline in the Class Action on Behalf of Iconix Brand Group, Inc. Investors
-
Roth Capital Positive on BioLineRx (BLRX) Following BL-8040 Phase 2b Initiation
-
Roth Affirms Clean Diesel Tech (CDTI) at 'Buy'; Still Sees Cash Shortfall in Early-FY16
-
Marathon Patent Group and Uniloc Agree to Merge
-
xG Technology (XGTI) Prices Class A, B Units Public Offering
-
xG Technology, Inc. Announces Pricing of Public Offering
-
Alcobra Ltd (ADHD) PT Raised to $16 at Roth Capital
-
Unusual 11 Mid-Day Movers 8/13: (CAPN) (PLNR) (OHGI) Higher; (BGMD) (MXPT) (LLNW) Lower
-
Streetinsider.com's Hot Lunchtime Reads 8/13: (QIHU) (AAPL) (OKE) (KERX)
-
ImmunoCellular (IMUC) SPA from FDA 'Significant', Roth Capital Says
-
Roth Capital Cuts Price Target on Ring Energy (REI) Following 2Q15
-
Notable Mergers and Acquisitions 8/13: (ECL)/(SWSH) (HMLP) (RHHBY) (FLO) (PLNR)
-
Pre-Open Stock Movers 08/13: (PLNR) (SUNE) (CSCO) Higher; (BGMD) (SHAK) (KSS) Lower (more...)

